Postoperative XXXX after lymph node dissection and primary @entity2 resection.

@entity1 @entity63 @entity2488 @entity26 @entity1149 @entity2 @entity292 @entity221
BACKGROUND: The purpose of this study was to determine the incidence and symptoms of @entity63 ( @entity63 ) after systematic lymph node dissection (LND) and evaluate the effect of hyperbaric @entity26 therapy in @entity1 with primary @entity2 . METHODS: From January 2004 to December 2009, 1,071 @entity1 underwent a standard resection for @entity1149 and radical systematic lymph node dissection. Fiberoptic bronchoscopy was performed systematically between days 7 and 12. We analyzed the clinical and biologic signs of @entity63 . Once the diagnosis established a treatment by hyperbaric @entity26 , therapy was undertaken. RESULTS: A @entity63 was observed in 34 @entity1 (3.21%) (2 @entity1 and 32 @entity1 ). Mean age was 59    10 years (range, 25 to 79 years). A @entity63 occurred within 8    3 days; after right pulmonary resection (n = 21; 62%) and after left resection (n = 13; 38%). A @entity63 appeared asymptomatically for 27 @entity1 (80%), whereas only 7 @entity1 (20%) presented with @entity221 and hyperleukocytosis. Their localization were @entity2488 (n = 21; 62%), homolateral bronchial tree (n = 11; 32%), or extension toward the contralateral bronchial tree (n = 2; 6%). The mean number of hyperbaric @entity26 therapy sessions was 14 (1 to 48). A @entity63 worsening was observed in 6 @entity1 (18%), requiring a surgical rescue therapy. CONCLUSIONS: The clinical presentation of @entity63 is poor and systematic fiberoptic bronchoscopy should be performed, especially in @entity1 with a high risk of @entity292 . Hyperbaric @entity26 therapy in the management of @entity63 may be a promising adjunctive treatment.
